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INTRODUCTION
Scoring systems have been continuously developed to pre-
dict outcomes in patients with severe illness, to improve re-
source allocation and to assist in clinical decision-making
particularly for intensive care unit (ICU) patients (1-3). Acute
physiology and chronic health evaluation II (APACHE II)
(4) and simplified acute physiology score II (SAPS II) (5) are
two representative systems currently in wide use for measur-
ing the condition of individual ICU patients (6, 7).
In these systems, the reliability of an outcome prediction
in a given population depends on the case mix of that popu-
lation because the underlying disease category has an indepen-
dent role in hospital stay outcomes in critically ill patients
(4, 7). However, these systems have not always proven valid
in specific patient populations such as those with septicemia
(7), HIV positive serum (8, 9), Pneumocystis carinii pneumo-
nia (10), cardiac diseases (11) or neoplastic diseases (12, 13).
Patients who are admitted to the neurosurgical ICU (NICU)
are likely in many instances to have higher mortality despite
multimodal intensive management, regardless of their neu-
rosurgical diagnosis. There have been some reports on the effi-
cacy of SAPS II in predicting the outcome for patients with
subarachnoid hemorrhage (SAH) and on APACHE II in trau-
matic brain injury (TBI) (14-16).
The purpose of this study is therefore twofold: first, to com-
pare the discriminating capability of APACHE II and SAPS
II score to predict mortality in a group of NICU patients; and
second, to assess the applicability of APACHE II and SAPS
II scores in two specific disease categories, SAH and TBI. In
doing so, the impact of systemic or extracerebral organ dys-
function on the outcome of acutely ill NICU patients will
be better defined and future direction identified. 
MATERIALS AND METHODS
Study population
Records of 705 consecutive patients who were admitted to
NICU from July 2003 through June 2005 were retrospective-
ly examined, and 672 of these were included in this study.
Thirty-three patients were excluded because of a chronic mori-
bund state at admission (n=9) or incomplete data gathering
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Acute Physiology and Chronic Health Evaluation II and Simplified
Acute Physiology Score II in Predicting Hospital Mortality of 
Neurosurgical Intensive Care Unit Patients
We study the predictive power of Acute Physiology and Chronic Health Evaluation
II (APACHE II) and Simplified Acute Physiology Score II (SAPS II) in neurosurgical
intensive care unit (ICU) patients. Retrospective investigation was conducted on
672 consecutive ICU patients during the last 2 yr. Data were collected during the
first 24 hours of admission and analyzed to calculate predicted mortality. Mortality
predicted by two systems was compared and, multivariate analyses were then per-
formed for subarachnoid hemorrhage (SAH) and traumatic brain injury (TBI) patients.
Observed mortality was 24.8% whereas predicted mortalities were 37.7% and 38.4%,
according to APACHE II and SAPS II. Calibration curve was close to the line of per-
fect prediction. SAPS II was not statistically significant according to a Lemeshow-
Hosmer test, but slightly favored by area under the curve (AUC). In SAH patients,
SAPS II was an independent predictor for mortality. In TBI patients, both systems
had independent prognostic implications. Scoring systems are useful in predicting
mortality and measuring performance in neurosurgical ICU setting. TBI patients are
more affected by systemic insults than SAH patients, and this discrepancy of pre-
dicting mortality in each neurosurgical disease prompts us to develop a more spe-
cific scoring system targeted to cerebral dysfunction.
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(n=24). According to the International Classification of Dis-
ease, 10th ed. (ICD-10), the main reason for admission was
diagnosis of neurosurgical disease at the time of hospital dis-
charge. For patients admitted to the ICU more than once dur-
ing a hospitalization episode, only data from the first admis-
sion were used.
Data collection
This retrospective study involved a careful review of all med-
ical charts including laboratory results. Patient data observed
during the first 24 hr of the hospital stay was collected to
obtain following variables: neurosurgical diagnosis, temper-
ature (℃), systolic and mean arterial blood pressure (mmHg),
heart rate, respiratory rate, PaO2 or FiO2 (mmHg), arterial
pH and bicarbonate, serum sodium, potassium, urea and cre-
atinine, urine output, serum white blood cell count, hemat-
ocrit, platelet count and bilirubin, age, type of admission, Glas-
gow Coma Scale (GCS) score, presence of chronic diseases
(chronic organ insufficiency) or immuno-compromised state.
When a patient died within the first 24 hr of admission, we
selected the most perturbed value of each variable during the
period between admission and death (4, 5).
For all patients, APACHE II and SAPS II scores were cal-
culated as described in the original literatures, as was the risk
of death according to the published logistic equations (4, 5).
The associated risks of hospital mortality were derived using
data from each patient’s ICU stay and predictive equations of
the respective scoring system. Severe chronic illnesses in-
cluded cirrhosis, New York Heart Association class IV heart
failure, chronic respiratory failure, end-stage renal disease,
and immuno-suppression. Hospital mortality was defined as
the number of patients who died during hospital stay, in-
cluding deaths in ICU.
Statistical analysis
Continuous variables were expressed as mean±standard
deviation (SD) and were compared using Standard t-test. Cat-
egorical values were expressed in absolute and relative fre-
quencies, and were analyzed using chi-square test with com-
mercially available statistical software (SPSS Ver. 10, Chica-
go, IL, U.S.A.). All variables with a P value >0.05 were ex-
cluded from the final models. Predicted mortality was cal-
culated using logistic regression formulae described in the
original articles (4, 5). Standardized mortality ratio (SMR)
was obtained by dividing observed mortality by predicted
mortality. The 95% confidence interval (CI) for SMR was
calculated using observed mortality as a Poisson variable, and
dividing its 95% CI by the predicted mortality (17).
Comparison of the two scoring systems for goodness-of-fit
and prediction ability was performed by various methods.
Calibration (the ability to provide a risk estimate correspond-
ing to observed mortality) was assessed using calibration
curves (2) and chi-square statistics as proposed by Lemeshow-
Hosmer to test the goodness of fit of the model (18). A receiv-
er operating characteristic (ROC) curve was built for each
severity index, and area under the ROC curve (AUC) (19)
was used to test the ability of the models to discriminate bet-
ween patients who survived or patients who did not.
For patients with SAH and TBI, we related hospital death
to baseline characteristics and SAPS II and APACHE II scores
during the first 24 hr after admission using a logistic re-
gression model that yielded a crude odds ratio (OR). Multi-
variate analyses were then calculated using a forward selec-
tion method. By using AUC of the corresponding ROC, dis-
criminating power was also evaluated. Finally, analyses of in-
dividual elements of SAPS II and APACHE II values were
entered in a multivariate logistic regression model with a
forward selection method. Variables with a P value >0.10
were excluded.
RESULTS
The main features of the study population are shown in
Table 1. There were 207 patients with TBI and 159 patients
with SAH.
Predicted mortality
Observed mortality during hospital stay was 24.8% (167/
672) and that during ICU stay was 21.4% (144/672). Mean
APACHE II and SAPS II values were 37.74% (range: 2-39)
*Includes ischemia or infarction (n=41), vascular malformation (n=17),
and otherwise unspecified intracranial bleeding (n=9). 
� Includes congeni-
tal anomaly (n=6), and demyelinating or degenerative disease (n=3).
SAH, subarachnoid hemorrhage; ICH, intracerebral hemorrhage; IVH,
intraventricular hemorrhage.
No. of patients  Percent
Median age (range) (yr) 56 (4-89) -
Female sex 306 45.53
Neurosurgical diagnosis
Tumor 87 12.94
Brain 73 10.86
Spine 14 2.08
Vascular 349 51.93
SAH 159 23.66
ICH or IVH 114 16.96
Others* 67 9.97
Trauma 222 33.03
Brain 207 30.8
Sole 121 18.00
Multiple 86 12.79
Spine 15 2.08
Infection 14 2.08
Others
� 9 1.33
Table 1. Characteristics of 672 patients enrolled422 S.-K. Park, H.-J. Chun, D.-W. Kim, et al.
and 38.39% (range: 15-90), respectively. Both systems were
highly correlated (Bravais-Pearson correlation coefficient,
0.86, P<0.01). The mean predicted risk of death for the over-
all patient population, survivors and non-survivors are listed
in Table 2. There was no significant difference of SMR bet-
ween the two predictive scoring systems (0.66 for APACHE
II and 0.65 for SAPS II). Fig. 1 depicts the distributions of
predicted risks for the two systems, both of were skewed to-
ward low scores.
Calibration and discrimination
The calibration curves for APACHE II and SAPS II scores
show that both were close to the line of perfect prediction
(Fig. 2). Table 3 shows the number of predicted deaths in
each scale and the number of observed deaths over probabil-
ity intervals of 10%. Comparison (as proposed by Lemeshow-
Hosmer) between the contingency tables using a homogene-
ity chi-square test provides a very significant P value for the
APACHE II scoring systems (P<0.01) but not for SAPS II
(P=0.07) (Table 4).
Discrimination was assessed by ROC curves. Comparison
of the AUC revealed a slightly better fit in favor of SAPS II
(area, 0.81 vs. 0.79 for APACHE II) (Fig. 3).
APACHE II, Acute physiology and chronic health evaluation II; SAPS II,
simplified acute physiology score II.
All Survivors Non-survivors P value
Number 672 528 144
Age (yr) 56.12±15.42 51.56±13.40 58.22±15.87 0.26
Male/ 366/306 288/240 78/66 0.51
Female
APACHE II  34.74±21.74 20.12±14.59 41.48±21.20 <0.001
mortality (%)
SAPS II  38.39±29.73 16.36±16.44 48.56±29.00 <0.001
mortality (%)
Table 2. The mean predicted risk of death for all patients, for the
survivors and for the non-survivors
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Fig. 1. Grouped distributions of predicted risk of hospital death for
APACHE II and SAPS II scores
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Fig. 2. Comparison of the calibration curves for APACHE II and SA-
PS II scores for hospital mortality prediction.
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Lemeshow-Hosmer chi-square statistics were 46.16, P<0.01 for APACHE
II and 13.09, P=0.07 for SAPS II.
APACHE II, Acute physiology and chronic health evaluation II; SAPS II,
simplified acute physiology score II.
APACHE II SAPS II Estimated
probability 
of death No.
Expected Observed
No.
Expected Observed
deaths death deaths death
0-0.1 174 13.3 6 241 15.1 17
0.1-0.2 156 21.8 20 221 29.8 22
0.2-0.3 164 40.5 28 38 9.7 6
0.3-0.4 71 22.9 18 37 13.1 13
0.4-0.5 64 29.3 23 25 11.3 9
0.5-0.6 28 15.4 13 26 14.6 18
0.6-0.7 15 9.3 12 29 18.3 16
0.7-0.8 20 14.7 17 20 15.0 15
0.8-0.9 8 6.7 6 25 21.6 20
0.9-1.0 1 0.9 1 8 7.5 8
Table 3. Evaluation of the goodness-of-fit of APACHE II and SAPS
II models of hospital mortality*APACHE II and SAPS II in NICU Mortality 423
Univariate and multivariate predictors for death in SAH
patients
In univariate analysis, SAPS II, patients’ age, GCS score
and Fisher grade showed predictive implications for hospital
death, while APACHE II did not. Moreover, SAPS II had a
“dose-dependent” relationship to death such that higher scores
suggested increased mortality. In APACHE II, only those of
the above tertiles showed such relation with death. Multivari-
ate analysis showed similar results, and the AUC was 0.82.
Although detailed analysis is not shown, systolic blood pres-
sure, heart rate, PaO2/FiO2, serum potassium, age, and GCS
scores were individual factors contributing to the univariate
predictors for mortality in SAPS II. In multivariate analysis,
systolic blood pressure, PaO2/FiO2, age, and GCS scores were
independent predictors of mortality (Table 5).
Univariate and multivariate predictors for death in TBI
patients
Univariate analysis showed that APACHE II, SAPS II, sex,
GCS score, presence of systemic injury, systolic blood pressure,
and PaO2 were predictors for hospital mortality in TBI pa-
tients. The main differences from SAH patients were a greater
contribution of systemic factors and exclusion of patients’ ages.
Both SAPS II and APACHE II also showed a “dose-depen-
dent” relationship to death, with higher scores indicating in-
creasing mortality. Multivariate analysis showed similar results,
and the AUC of 0.88 was more discriminating than for pati-
ents with SAH. Systolic and mean arterial blood pressure,
heart rate, PaO2 or FiO2, arterial pH and bicarbonate, serum
urea and creatinine, urine output, and GCS score were con-
tributing factors for SAPS II and APAVHE II in univariate
analysis. In multivariate analysis, independent prognostic fac-
*Using calibration curves, the ability to provide a risk estimate correspond-
ing to observed mortality was assessed between two systems and it
showed equal result. Using Lemeshow-Hosmer method, 
2 statistics
was calculated to test the goodness of fit of the model between the con-
tingency tables and it provided a very significant p-value for the APACHE
II scoring system (P<0.01) but not for SAPS II (P=0.07). 
� Using AUC,
the ability to discriminate between patients who survived and patients
who did not was assessed. Comparison of the AUC revealed a slightly
better fit in favor of SAPS II (area, 0.81 vs. 0.79 for APACHE II).
ICU, intensive care unit; APACHE II, Acute physiology and chronic health
evaluation II; SAPS II, simplified acute physiology score II; ROC, receiver
operating characteristic curve.
ICU mortality
Mortality
APACHE II predicted, 34.74% Observed, 21.4%
SAPS II predicted, 38.39%
Goodness-of-fit*
Calibration curves APACHE II≒SAPS II
Lemeshow-Hosmer method APACHE II (P<0.01) > SAPS II
(P=0.07)
Discrimination
�
Area under the ROC curve APACHE II (0.79) < SAPS II 
(0.81)
Prognostic factor analysis APACHE II = SAPS II (P<0.01)
Table 4. Comparison of the scoring systems performances to pre-
dict ICU and hospital mortality
SAH, subarachnoid hemorrhage; APACHE II, acute physiology and chro-
nic health evaluation II; SAPS II, simplified acute physiology score II; GCS,
Glasgow coma scale; AUC, area under the curve; ROC, receiver oper-
ating characteristic curve.
Univariate analysis
Variables Odds ratio (95% CI)
Multivariate analysis
Variables
APACHE II (continuous) 1.04 (0.89-1.14)
SAPS II (continuous) 1.5 (1.1-2.3)
SAPS II (tertiles)
15-31 Reference
32-53 5.7 (2.1-15.3)
54-90 34.8 (10.6-98.7)
Age (continuous) 1.08 (1.02-1.13)
Sex (male) 1.17 (0.69-2.38)
GCS score (continuous) 7.2 (1.8-16.2)
Fisher grade 8.8 (3.4-19.6)
GCS score <12 3.7 (1.6-9.1)
Fisher grade≥3 5.8 (2.7-10.3)
APACHE II 1.05 (0.98-1.12)
SAPS II 1.37 (1.18-1.94)
AUC of ROC 0.82 (0.70-0.89)
Table 5. Univariate and multivariate analyses of predictors for hos-
pital death in SAH patients (n=159)
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Fig. 3. Discriminative ability of clinical prediction rules (outcome=
death) derived from APACHE II and SAPS II scoring systems
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tors were the same as for the univariate results except for the
exclusion of heart rate, serum creatinine level, and urine out-
put (Table 6). 
DISCUSSION
General perspectives of APACHE II and SAPS II 
Illness severity scoring systems are becoming more impor-
tant tools for measuring ICU performance and outcome, allo-
cating resources, triage of patients, and quality assurance. In
the future, such scoring systems will play a larger role in finan-
cial reimbursement or even accreditation for individual crit-
ical care units (20). As stated previously, the APACHE II
and SAPS II systems are based on multiple logistic regres-
sion equations that describe abnormalities in multiple phys-
iologic variables during the first 24 hr in the ICU, because
many deaths occur soon after admission (4, 5). These scores
are used to categorize patients in clinical trials and to com-
pare units with a calculation of the probability for hospital
death and SMR. This has been assumed to be an indicator
of ICU performance where unity implies that observed per-
formance matches expected performance. 
These scores have been tested in a wide range of patient
populations with different results (21-23). Owing to pre-exist-
ing or accompanying cerebral insult, patients admitted to
NICU tended to show more unfavorable outcomes compared
with non-NICU patients, and this is verified in our previ-
ous report (24). In this paper, however, we did not assess the
relationship between such scoring systems and individual
patient outcomes. This fact prompted us to investigate the
discriminative power of SAPS II and APACHE II in predict-
ing the hospital mortality of NICU patients. In both systems,
predicted mortality was much higher than actual mortality.
This might be attributed to surgical intervention, resuscita-
tion in the emergency room, or altered physiologic factors
observed more than 24 hr after admission that were unfore-
seen, or inherent to the cerebral pathophysiologic process.
Scoring systems in patients with SAH and TBI
In this study, the amount of extravasated blood clot on
CT scan (Fisher grade) and the level of consciousness at admis-
sion (GCS) are still the most important determinants predict-
ing mortality of SAH patients. However, GCS assessment
only accounts for 15/71 (21.1%) in APACHE II score and
15/163 (9.2%) in SAPS II score. Moreover, Fisher grade is
not included in the APACHE II and SAPS II scoring systems.
Therefore, a separate or complementary measurement scale
must be added or prepared when considering this specific
condition. Instead, these systems have systemic, extra-cere-
bral indices of organ dysfunction, which was tailored to aver-
age physiologic variables. Age and cardio-pulmonary param-
eters (systolic blood pressure, PaO2/FiO2) are proven inde-
pendent predictors for mortality. Myocardial stunning and
neurogenic pulmonary edema mediated by systemic cate-
cholamine surge are well-known systemic manifestations
following SAH. They present as ischemic heart disease show-
ing ST segment depression, T wave inversion on electrocar-
diography, or ventilatory dysfunction showing effusion or
inflammatory infiltration into the alveoli (25, 26). 
According to Claassen et al. (27), hypoxemia, metabolic
acidosis, hyperglycemia and cardiovascular instability within
24 hr of admission were independent prognosticators of death
or severe disability in SAH patients. It is interesting that
physiologic derangements besides the above-mentioned fac-
tors and the presence of systemic inflammatory response syn-
drome (SIRS) have been continuously suggested to have prog-
nostic implications (25). APACHE II and SAPS II scores have
all theses factors in their automated calculation tables. We
cannot determine exactly why the APACHE II score did not
reach statistical significance while the SAPS II score did. Inclu-
sion or exclusion of co-morbidity is deemed a main differen-
tial point between two systems. 
TBI, traumatic brain injury; APACHE II, acute physiology and chronic
health evaluation II; SAPS II, simplified acute physiology score II; GCS,
Glasgow coma scale; AUC, area under the curve; ROC, receiver oper-
ating characteristic curve.
Univariate analysis
Variables Odds ratio (95% CI)
Multivariate analysis
Variables
APACHE II (continuous) 1.25 (1.12-1.44)
APACHE II (tertiles)
2-15 Reference
16-23 3.54 (1.52-7.04)
24-39 29.18 (8.94-54.72)
SAPS II (continuous) 1.71 (1.31-2.68)
SAPS II (tertiles)
15-33 Reference
34-52 7.7 (2.8-18.4)
53-90 41.5 (14.6-99.8)
Age (continuous) 1.08 (0.79-1.31)
Sex (male) 1.29 (1.05-1.92)
GCS score (continuous) 4.6 (2.1-12.3)
Systemic injury (+) (n=86) 6.9 (2.9-15.2)
Blood pressure (systolic) 2.6 (1.5-4.4)
PaO2 (continuous) 1.9 (1.1-3.3)
GCS score <12 2.9 (1.8-6.2)
Blood pressure <90 (mmHg) 4.4 (2.3-12.5)
PaO2 <90 (%) 3.1 (1.7-7.4)
Systemic injury (+) (n=86) 5.7 (3.5-8.2)
APACHE II  1.5 (1.2-2.8)
SAPS II 2.3 (1.7-5.8)
AUC of ROC 0.88 (0.81-0.94)
Table 6. Univariate and multivariate analyses of predictors for hos-
pital death in TBI patients (n=207)APACHE II and SAPS II in NICU Mortality 425
The ideal ICU scoring system should provide a predictive
basis for decision-making in individual patients as well as a
comparative assessment of ICU performance. Most scoring
systems have been constructed in general ICU populations
and were therefore not validated for specific patients or groups.
This has been especially true for TBI patients, who are younger
and do not have chronic health problems frequently seen in
an older patients, resulting in underestimated predicted mor-
tality (28). The main finding in the present study is that
patient age was not related to hospital death, whereas TBI
patients were more likely to die as the severity of accompa-
nying systemic injury increased. Both APACHE II and
SAPS II systems had statistical significance with mortality
in a dose-dependent fashion. The impact of GCS score and
cardiopulmonary dysfunctions (low blood pressure, low oxy-
gen saturation) were similar to those of SAH patients. 
Limitation and future direction
Although these scoring systems have certain advantages,
limitations still exist in routine use. First, although these
scores were prospectively recorded by medical personnel, a
bias due to differences in calculating scores and validating
patient-derived parameters cannot be completely excluded.
Post-hoc verification on all processes of data interpretation
will be necessary. Second, this study was conducted at only
one center. The results therefore, reflect the outcome of spe-
cific patients in a tertiary care center and may not be gener-
ally applicable to all hospitals in all cases. However, the study
gives some insight into this issue, at least from a tertiary care
perspective. Third, data collection and compilation have been
identified as problems with the APACHE II and SAPS II sys-
tems (29). Lead time bias, the question of where the patients
came from and how long they were in the hospital prior to
ICU admission may influence outcome (30). Fourth, the scor-
ing systems are not adequate to make decisions for the man-
agement of individual patients due to the relatively high mor-
tality rate predicted in survivors and the low one predicted
in non-survivors. APACHE II and SAPS II scores differed
significantly in individual patient populations, and these sever-
ity scores are not accurate enough to be used in the routine
management of these patients. The appropriate allocation of
limited resources available must be addressed. However, the
decision to withdraw life support must not rely entirely on
these scoring systems. Instead, alterations of management
planning such as instituting surgical treatment, reinforcing
pharmacological or medical intervention or transferring pat-
ients to non-NICU, should be considered (14). 
In spite of these limitations, we were able to obtain some
helpful findings when assessing hospital mortality using
APACHE II and SAPS II in NICU patients. First, there was
a significant increase in observed mortality when APACHE
II or SAPS II scores increased. Both systems, however, over-
estimated mortality. The SMR was significantly below 1.0
in both scoring groups. An SMR below 1.0 may have at least
three different explanations: selection of less severe patients,
good clinical performance, or error of the system itself. Sec-
ond, calibration and discrimination was good for both sys-
tems. Correlation between the APACHE II and SAPS II was
excellent, but this is not surprising, given the overlap in the
variables considered. Score prediction was tested using crite-
ria suitable to evaluate the calibration and discrimination
properties of an outcome prediction score. The calibration
curves, comparing observed proportions with predicted pro-
portions of hospital death, were virtually identical. The dis-
tribution of the calculated probability of hospital death in
both APACHE II and SAPS II were both skewed toward the
low score values. Third, there was no major difference in pre-
dicting hospital mortality according to goodness-of-fit of the
model, as shown by the calibration curves. However, when
assessed by the Lemeshow-Hosmer method, APACHE II was
statistically significant whereas SAPS II was not. Discrimi-
nation between survivors and non-survivors appeared to be
slightly superior with SAPS II according to the AUC (Fig. 3).
To obtain a better discrimination, more research is needed to
define new variables based not on expert opinion but rather
on statistical models (6, 31). Finally, if a certain variable were
included in this system and consecutively checked, evaluation
of new therapies, surveillance of resource utilization, and qual-
ity assessment of each ICU would be possible, in addition to
outcome prediction. 
In summary, we conclude that both APACHE II and SAPS
II score systems can be used to approximately predict in-hos-
pital mortality of neurosurgical ICU patients, but not to mea-
sure performance or to help in definite clinical decision-mak-
ing. Neither can be relied on to provide prognostic informa-
tion for an individual patient. There was some discordance
between predictive implications in both systems, particular-
ly in the two different disease categories of SAH and TBI
patients. Although the ideal scoring system has yet to be devel-
oped and no system has ever been demonstrated to be com-
pletely reliable, the ongoing improvement of existing systems
should no doubt continue.
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